Hims & Hers Health Overview
Hims & Hers Health Target Price
Analysts' 12-month price predictions for HIMS.
Share Price
$46.28
Average Target Price
$65.00
40.4% upside
40.4% upside1 analysts in the last 4 months
High: $65 | Low: $65
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-06-04 | NeedhamRyan Macdonald | $65 | 40.4% upside |  |
| 2025-02-19 | Canaccord GenuityMaria Ripps | $68 | 46.9% upside | |
| 2024-12-02 | Canaccord GenuityMaria Ripps | $38 |  17.9% downside | |
| 2024-11-05 | Piper SandlerKorinne Wolfmeyer | $21 | 54.6% downside | |
| 2024-11-05 | NeedhamRyan MacDonald | $28 | 39.5% downside | |
| 2024-10-29 | Leerink PartnersMichael Cherny | $26 | 43.8% downside | |
| 2024-10-21 | Bank of America SecuritiesMichael Cherny | $25 | 46% downside | |
| 2024-10-14 | Bank of America SecuritiesMichael Cherny | $23 | 50.3% downside | |
| 2024-10-14 | Truist FinancialJailendra Singh | $23 | 50.3% downside | |
| 2024-09-13 | Bank of America SecuritiesAllen Lutz | $20 | 56.8% downside | |
| 2024-08-27 | CitigroupDaniel Grosslight | $20 | 56.8% downside | |
| 2024-08-07 | JefferiesGlen Santangelo | $18 | 61.1% downside | |
| 2024-08-06 | Deutsche BankGeorge Hill | $23 | 50.3% downside | |
| 2024-05-22 | Canaccord GenuityMaria Ripps | $24 | 48.1% downside | |
| 2024-05-07 | JefferiesGlen Santangelo | $14 | 69.7% downside | |
| 2024-05-07 | Truist FinancialJailendra Singh | $13 | 71.9% downside | |
| 2024-05-07 | Piper SandlerKorinne Wolfmeyer | $13 | 71.9% downside | |
| 2024-05-07 | Deutsche BankGeorge Hill | $16 | 65.4% downside | |
| 2024-04-16 | JefferiesGlen Santangelo | $15 | 67.6% downside | |
| 2024-04-10 | Canaccord GenuityMaria Ripps | $20 | 56.8% downside | |
| 2022-08-10 | Credit Suisse | $8 | 82.7% downside | |
| 2022-08-09 | Leerink Partners | $5 | 89.2% downside | |
| 2022-05-26 | Piper Sandler | $6 | 87% downside | |